Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).
暂无分享,去创建一个
M. Budoff | R. Detrano | J. Probstfield | M. Shlipak | R. Katz | J. Ix | J. Takasu | D. Shavelle | K. O’Brien | M. Budoff
[1] S. Tett,et al. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis. , 2007, Clinical biochemistry.
[2] R. Kronmal,et al. Features of the Metabolic Syndrome and Diabetes Mellitus as Predictors of Aortic Valve Calcification in the Multi-Ethnic Study of Atherosclerosis , 2006, Circulation.
[3] P. Chaves,et al. Cardiovascular morbidity and mortality in community-dwelling elderly individuals with calcification of the fibrous skeleton of the base of the heart and aortosclerosis (The Cardiovascular Health Study). , 2006, The American journal of cardiology.
[4] R. Kronmal,et al. Reproducibility of CT measurements of aortic valve calcification, mitral annulus calcification, and aortic wall calcification in the multi-ethnic study of atherosclerosis. , 2006, Academic radiology.
[5] D. Levy,et al. Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. , 2006, Journal of the American Society of Nephrology : JASN.
[6] P. Raggi,et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. , 2005, Kidney international.
[7] K. Hunt,et al. Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes. , 2005, Kidney international.
[8] Kiang Liu,et al. Urine Albumin Excretion and Subclinical Cardiovascular Disease , 2005, Hypertension.
[9] R. Nelson,et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. , 2005, Journal of the American Society of Nephrology : JASN.
[10] W. Aronow,et al. Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure. , 2005, The American journal of cardiology.
[11] R. Detrano,et al. Ethnic Differences in Coronary Calcification: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2005, Circulation.
[12] R. Cooper,et al. Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study. , 2005, Journal of the American Society of Nephrology : JASN.
[13] R. Detrano,et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. , 2005, Radiology.
[14] T. Larson,et al. Using Serum Creatinine To Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease , 2004, Annals of Internal Medicine.
[15] V. Andreucci,et al. Coronary artery calcification in patients with CRF not undergoing dialysis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] R. Toto. Microalbuminuria: Definition, Detection, and Clinical Significance , 2004, Journal of clinical hypertension.
[17] D. Levy,et al. Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease: the Framingham Heart Study. , 2004, Kidney international.
[18] Charles E McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[19] P. Aliabadi,et al. Intact parathyroid hormone levels in renal insufficiency , 1995, Calcified Tissue International.
[20] P. Raggi,et al. Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer. , 2004, The Journal of heart valve disease.
[21] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[22] J. Woo,et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. , 2003, Journal of the American Society of Nephrology : JASN.
[23] R. Kronmal,et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.
[24] C. Otto,et al. Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma , 2002, Circulation.
[25] P. Raggi,et al. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. , 2002, Kidney international.
[26] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] P. Raggi,et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? , 2002, Journal of the American College of Cardiology.
[28] S. Seliger,et al. Gender and the progression of renal disease , 2001, Current opinion in nephrology and hypertension.
[29] T. Mazzone,et al. Increased prevalence of significant coronary artery calcification in patients with diabetes. , 2001, Diabetes care.
[30] D. Fliser,et al. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[31] E. Mohler. Are atherosclerotic processes involved in aortic-valve calcification? , 2000, The Lancet.
[32] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[33] E. Randers,et al. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. , 1999, Scandinavian journal of clinical and laboratory investigation.
[34] T. Callister,et al. Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. , 1998, Radiology.
[35] Sílvia Ribeiro,et al. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[36] R. Zinck,et al. Cystatin C--a new marker of glomerular filtration rate in children independent of age and height. , 1998, Pediatrics.
[37] R. Saracho,et al. The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[38] Catherine M. Otto,et al. Clinical Factors Associated With Calcific Aortic Valve Disease , 1997 .
[39] E. Mohler,et al. Detection of osteopontin in calcified human aortic valves. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[40] M. Antos,et al. Frequency of mitral annular calcification in patients on hemodialysis estimated by 2-dimensional echocardiography. , 1996, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.
[41] M. Ferguson,et al. Osteopontin is expressed in human aortic valvular lesions. , 1995, Circulation.
[42] C. Price,et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. , 1995, Kidney international.
[43] R. Detrano,et al. Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.
[44] E. Maher,et al. AORTIC AND MITRAL VALVE CALCIFICATION IN PATIENTS WITH END-STAGE RENAL DISEASE , 1987, The Lancet.
[45] G. Berti,et al. Enzymic creatinine assay: a new colorimetric method based on hydrogen peroxide measurement. , 1983, Clinical chemistry.
[46] M. Tidd,et al. Letter: Safeguards for healthy volunteers in drug studies. , 1975, Lancet.
[47] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[48] J. Kassirer,et al. Clinical evaluation of kidney function--glomerular function. , 1971, The New England journal of medicine.